MPWT
XERS icon

MassMutual Private Wealth & Trust’s Xeris Biopharma Holdings XERS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.03K Sell
888
-246
-22% -$1.57K ﹤0.01% 1553
2026
Q1 		$6.58K Buy
1,134
+456
+67% +$3.02K ﹤0.01% 1551
2025
Q4 		$5.32K Sell
678
-216
-24% -$1.7K ﹤0.01% 1653
2025
Q3 		$7.28K Buy
894
+340
+61% +$2.26K ﹤0.01% 1526
2025
Q2 		$2.59K Buy
554
+134
+32% +$614 ﹤0.01% 1877
2025
Q1 		$2.31K Buy
+420
New +$1.7K ﹤0.01% 1875
2022
Q4 		– Sell
-986
Closed -$2K – 1888
2022
Q3 		$2K Buy
+986
New +$1.63K ﹤0.01% 1309

Other funds holding XERS

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.82B AUM 30.02% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return